Arth RX Topical Analgesic
- Manufacturer
- HCD Sales
- Effective date
- 2023-11-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-05-31 23:59:04
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose Methyl nicotinate 0.5% External Analgesic Capsaicin 0.025 % External Analgesic
OTC - PURPOSE SECTION
Uses: Temporarily relieves minor aches and pains of muscles and joints due to:
- Arthritis - Strains - Sprains
WARNINGS SECTION
WARNINGS
FOR EXTERNAL USE ONLY
INDICATIONS & USAGE SECTION
When Using This Product
- Avoid contact with eyes - Do not apply to wounds or damaged skin - Do not bandage tightly
OTC - STOP USE SECTION
Stop use and ask doctor if
- Condition worsens - Excessive irritation of the skin develops - Pain persists for more than 7 days - Symptoms clear up and occur again within a few days
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a poison control center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions - Adults apply to affected area no more than 3-4 times daily - Children under 18 consult a physician - Apply to small area of the skin as test for sensitivity at least 60 minutes prior to applying to wide area.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Isopropanol, water, extracts of arnica and rue, polyacrylamide, C 13-14 isoparaffin. tween 80, laureth-7, boswellia, extract of chamomile, aloe, fragrance.
OTC - QUESTIONS SECTION
Questions or comments
Toll free 1-800-729-8446
DESCRIPTION SECTION
Products containing capsaicin may cause a burning, stinging or tingling sensation where applied. This is a natural reaction and varies with each individual usually decreasing or disappearing after continued use. Please read package insert prior to use. .......... may be removed from the test area by wiping or olive oil.
Distributed by: HCD sales, Inc, Tampa, FL 33549
www.hcdsales.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
arth.Rx TOPICAL ANALGESIC ARTHRITIS PAIN RELIEF PENETRATING PAIN RELIEF, DOUBLE ACTION FORMULA WITH DOCTOR RECOMMENDED CAPSAICIN NEW WT 3 OZ (85 g)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1094383 | Arth-Rx Topical Analgesic (capsaicin 0.025 % / methyl nicotinate 0.5 % ) Topical Lotion | PSN | 5 |
| 1094379 | capsaicin 0.025 % / methylnicotinate 0.5 % Topical Lotion | PSN | 5 |
| 1094383 | capsaicin 0.25 MG/ML / methylnicotinate 5 MG/ML Topical Lotion [Arth-RX] | SBD | 5 |
| 1094379 | capsaicin 0.25 MG/ML / methylnicotinate 5 MG/ML Topical Lotion | SCD | 5 |
| 1094383 | Arth-Rx Topical Analgesic (capsaicin 0.025 % / methyl nicotinate 0.5 % ) Topical Lotion | SY | 5 |
| 1094379 | capsaicin 0.025 % / methylnicotinate 0.5 % Topical Lotion | SY | 5 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| NIACIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 473d070d-1c38-488e-b991-c4d1bf45aab8 | Product name | 1 | 20210201 |
| e2dae634-14ed-febf-08ee-93196433b5b7 | Product name | 9 | 20190614 |
| 0a5e5249-329b-0cff-e714-77159f193a87 | Product name | 1 | 20140508 |
| 6b7a6f32-42a6-994d-5ab6-d180e92ee9d8 | Product name | 1 | 20140508 |
| d394f843-7479-dc48-dbd3-232266c5548c | Product name | 1 | 20140508 |
| dc9a5fb6-14e2-1cc8-a567-a781fd1f0212 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76069-100-03 | Arth RX Topical Analgesic | 85 g in 1 BOTTLE | LOTION | 85 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAPSAICIN | ACTIVE INGREDIENT | S07O44R1ZM | 2 | |
| METHYL NICOTINATE | ACTIVE INGREDIENT | 7B1AVU9DJN | 2 | |
| CAPSAICIN | ACTIVE MOIETY | S07O44R1ZM | 2 | |
| METHYL NICOTINATE | ACTIVE MOIETY | 7B1AVU9DJN | 2 | |
| ALOE | INACTIVE INGREDIENT | V5VD430YW9 | 2 | |
| C13-14 ISOPARAFFIN | INACTIVE INGREDIENT | E4F12ROE70 | 2 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | 2 | |
| LAURETH-7 | INACTIVE INGREDIENT | Z95S6G8201 | 2 | |
| POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD) | INACTIVE INGREDIENT | 0L414VCS5Y | 2 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Arth RX Topical Analgesic
- METHYL NICOTINATE, CAPSAICIN
- ISOPROPYL ALCOHOL
- WATER
- POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD)
- C13-14 ISOPARAFFIN
- POLYSORBATE 80
- LAURETH-7
- ALOE
- METHYL NICOTINATE
- NIACIN
- CAPSAICIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76069-100 | 76069-100-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| WATER | 059QF0KO0R | IACT |
| POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD) | 0L414VCS5Y | IACT |
| C13-14 ISOPARAFFIN | E4F12ROE70 | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| LAURETH-7 | Z95S6G8201 | IACT |
| ALOE | V5VD430YW9 | IACT |
| METHYL NICOTINATE | 7B1AVU9DJN | ACTIB |
| CAPSAICIN | S07O44R1ZM | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD) | POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) | 0L414VCS5Y | SHAMPOO / TOPICAL | 1 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD) | POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) | 0L414VCS5Y | SHAMPOO / TOPICAL | 1 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arth RX Topical Analgesic | METHYL NICOTINATE, CAPSAICIN | HCD Sales | a7b3b9b4-b1c4-4e51-8e3a-c84f64c75609 | 2023-11-06 | Warnings | 76069-100-03 76069-100 76069010003 0975eb87-fa94-1621-e063-6394a90a9880 a7b3b9b4-b1c4-4e51-8e3a-c84f64c75609 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
